Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have ...

Several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg have been found in the United States. The FDA ...

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, and growing consumer demand ...

A new international clinical trial has shown that the oral form of semaglutide, a medication already known for managing type ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

Also Read: Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients ... and remain at high risk of disease progression. Participants are randomized ...

Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...